TRIPS and the global pharmaceutical market.
TRIPS and the global pharmaceutical market.
复制标题
TRIPS 和全球医药市场。
作者：
J. Barton
本文回顾了发展中国家在专利和药品获取方面的国际争议，并探讨了1995年《与贸易有关的知识产权协议》（TRIPS）、2001年《多哈宣言》和2003年坎昆会议前达成的协议的影响。这些协定并没有解决发展中国家在寻求获得药物时面临的重要资金问题。此外，国际辩论及其解决方案将使外国药品进口到美国变得更加复杂，并加强了扩大公众对美国药品采购的支持的压力，从长远来看，这将使美国药品定价受到政治控制。
This paper reviews the international controversy over patents and access to drugs in developing countries and explores the implications of the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement, the 2001 Doha Declaration, and the 2003 agreement preceding the Cancun meeting. These agreements do not resolve the important funding issues that developing countries confront as they seek access to drugs. Also, the international debate and its resolution will complicate the importing of foreign pharmaceuticals into the United States and strengthen pressures both for expanding public support of U.S. drug purchases and, in the long run, for political control of U.S. pharmaceutical pricing.